Structure determination of 3β-acetoxy-cholest-5-ene-7-one—A steroid

The crystal structure of 3β-acetoxy-cholest-5-ene-7-one (C₂₉H₄₆O₃) has been determined by X-ray diffraction methods. The compound crystallizes in the monoclinic crystal system (space group P2₁) with the unit cell parameters a = 9.632(1) Å, b = 12.280(1) Å, c = 23.099(2) Å, β = 99.52(1)°, and Z = 4. The structure has been solved by direct methods and refined to an R-value of 0.065 for 3927 observed reflections [F ₀ > 4σ(F ₀)]. Two crystallographically independent molecules (I and II) in the asymmetric unit have been observed. In both molecules, rings A and C of the steroid nucleus exist in a chair conformation. Ring B of molecule I adopts a 5α,6β half-chair conformation, and ring B of molecule II shows a 6α sofa conformation. Ring D adopts a 13α,14β half-chair conformation in molecule I and a 13α,14β half-chair conformation in molecule II. The crystal structure is stabilized by the intramolecular and intermolecular C-H?O interactions.     

PHOTOCYCLOADDITION OF ACETONE TO URACIL AND CYTOSINE

Abstract— Ultraviolet irradiation (Λ > 280 nm) of uracil in aqueous acetone (1:1) produces cyclobutane uracil dimer and uracil-acetone addition product. The addition product is identified as an oxetane. The same product is also obtained from cytosine irradiated under the same conditions. The cytosine-acetone oxetane apparently undergoes deamination readily. Irradiation (Λ= 265 nm) of the oxetane in aqueous solution produces acetone and uracil with a quantum efficiency of 0–16.     

Intramolecular pi-stacking interaction in a rigid molecular hinge substituted with 1-(pyrenylethynyl) units

Synthesis of a tetrakis(1-pyrenylethynyl)-substituted rigid hinge-like molecule (1) is described. The intramolecular pi-stacking interaction of the pyrene units is studied by 1H NMR and fluorescence spectroscopy. Due to intramolecular pi-stacking interactions, chemical shifts of the pyrene protons in 1 are highly shielded in the NMR spectrum. Fluorescence from the static excimer state is observed due to pi-stacking interactions among the pyrene units in the ground state of 1. Based on the spectroscopic evidence, conformations and dynamics of 1, arising from the hindered rotation of the major axis, are proposed.     

Determination of rosuvastatin and ezetimibe in a combined tablet dosage form using high-performance column liquid chromatography and high-performance thin-layer chromatography

This paper describes validated HPLC and HPTLC methods for the simultaneous determination of rosuvastatin (ROS) and ezetimibe (EZE) in a combined tablet dosage form. The isocratic RP-HPLC analysis was performed on a Chromolith C18 column (100 x 6 mm id) using 0.1% (v/v) orthophosphoric acid solution (pH 3.5)-acetonitrile (63 + 37, v/v) mobile phase at a flow rate of 1 mL/min at ambient temperature. Quantification was carried out using a photodiode array UV detector at 245 nm over the concentration range of 0.5-10 microg/mL for ROS and EZE. The HPTLC separation was carried out on an aluminum-backed sheet of silica gel 60F(254) layers using n-butyl acetate-chloroform-glacial acetic acid (1 + 8 + 1, v/v/v) mobile phase. Quantification was achieved with UV densitometry at 245 nm over a concentration range of 0.1-0.9 micro/spot for ROS and EZE. The analytical methods were validated according to International Conference on Harmonization guidelines. Low RSD values indicated good precision. Both methods were successfully applied for the analysis of the drugs in laboratory-prepared mixtures and commercial tablets. No chromatographic interference from the tablet excipients was found. These methods are simple, precise, and sensitive, and are applicable for simultaneous determination of ROS and EZE in pure powder and tablets.     

Synthesis,structural characterization and catalytic activity study of Mn(II), Fe(III), Ni(II), Cu(II) and Zn(II) complexes of quinoxaline-2-carboxalidine-2-amino-5-methylphenol: Crystal structure of the nickel(II) complex

Five new transition metal complexes [MnL(OAc)]·H₂O (1), [FeLCl₂] (2), [NiL₂]·H₂O (3), [CuLCl] (4) and [ZnL₂]·2H₂O (5) have been synthesized using a tridentate Schiff base ligand, HL (quinoxaline-2-carboxalidine-2-amino-5-methylphenol) and the complexes have been characterized by physicochemical and spectroscopic techniques. The spectral analyses reveal an octahedral geometry for 3, square pyramidal structure for 2 and square planar structure for 4. Analytical and physicochemical data indicate tetrahedral structure for 1 and octahedral structure for 5. The crystallographic study reveals that [NiL₂]·H₂O shows distorted octahedral geometry with a cis arrangement of N₄O₂ donor set of the bis Schiff base and exhibits a two-dimensional polymeric structure parallel to [0 1 0] plane. The complexes were screened for catalytic phenol hydroxylation reaction. Coordinatively unsaturated manganese(II), iron(III) and copper(II) complexes were found to be active catalysts. The poor catalytic activity of the nickel(II) complex is due to coordinatively saturated octahedral nature of the complex. Maximum conversion of phenol was observed for the copper(II) complex and the major product was catechol.     

Bis[2,4‐diamino‐5‐(3,4,5‐trimethoxybenzyl)pyrimidin‐1‐ium] dl‐malate

<!?tpct=1pt>Racemic malic acid and trimethoprim [5‐(3,4,5‐trimethoxybenzyl)pyrimidine‐2,4‐diamine] form a 1:2 salt (monoclinic, P2₁/c), 2C₁₄H₁₉N₄O₃⁺·C₄H₄O₅²⁻, in which the malate component is disordered across a centre of inversion. The crystal structure of the salt consists of protonated trimethoprim residues and a malate dianion. The carboxylate group of the malate ion interacts with the trimethoprim cation in a linear fashion through pairs of N—H...O hydrogen bonds to form a cyclic hydrogen‐bonded motif. This is similar to the carboxylate–trimethoprim cation interaction observed earlier in the complex of dihydrofolate reductase with trimethoprim. The structure of the salt of trimethoprim with racemic dl ‐malic acid reported here is the first of its kind. The present study investigates the conformations and the hydrogen‐bonding interactions, which are very important for biological functions. The pyrimidine plane makes a dihedral angle of 78.08 (7)° with the benzene ring of the trimethoprim cation. The cyclic hydrogen‐bonded motif observed in this structure is self‐organized, leading to novel types of hydrogen‐bonding motifs in supramolecular patterns.     

Two novel bis‐azomethines derived from quinoxaline‐2‐carbaldehyde

The Schiff base compounds N,N′‐bis[(E)‐quinoxalin‐2‐ylmethylidene]propane‐1,3‐diamine, C₂₁H₁₈N₆, (I), and N,N′‐bis[(E)‐quinoxalin‐2‐ylmethylidene]butane‐1,4‐diamine, C₂₂H₂₀N₆, (II), crystallize in the monoclinic crystal system. These molecules have crystallographically imposed symmetry. Compound (I) is located on a crystallographic twofold axis and (II) is located on an inversion centre. The molecular conformations of these crystal structures are stabilized by aromatic π–π stacking interactions.     

From Metallaborane to Borylene Complexes: Syntheses and Structures of Triply Bridged Ruthenium and Tantalum Borylene Complexes

Reaction of [1,2‐(Cp*RuH)₂B₃H₇] ( 1 ; Cp*=η⁵‐C₅Me₅) with [Mo(CO)₃(CH₃CN)₃] yielded arachno‐[(Cp*RuCO)₂B₂H₆] ( 2 ), which exhibits a butterfly structure, reminiscent of 7 sep B₄H₁₀. Compound 2 was found to be a very good precursor for the generation of bridged borylene species. Mild pyrolysis of 2 with [Fe₂(CO)₉] yielded a triply bridged heterotrinuclear borylene complex [(μ₃‐BH)(Cp*RuCO)₂(μ‐CO){Fe(CO)₃}] ( 3 ) and bis‐borylene complexes [{(μ₃‐BH)(Cp*Ru)(μ‐CO)}₂Fe₂(CO)₅] ( 4 ) and [{(μ₃‐BH)(Cp*Ru)Fe(CO)₃}₂(μ‐CO)] ( 5 ). In a similar fashion, pyrolysis of 2 with [Mn₂(CO)₁₀] permits the isolation of μ₃‐borylene complex [(μ₃‐BH)(Cp*RuCO)₂(μ‐H)(μ‐CO){Mn(CO)₃}] ( 6 ). Both compounds 3 and 6 have a trigonal‐pyramidal geometry with the μ₃‐BH ligand occupying the apical vertex, whereas 4 and 5 can be viewed as bicapped tetrahedra, with two μ₃‐borylene ligands occupying the capping position. The synthesis of tantalum borylene complex [(μ₃‐BH)(Cp*TaCO)₂(μ‐CO){Fe(CO)₃}] ( 7 ) was achieved by the reaction of [(Cp*Ta)₂B₄H₈(μ‐BH₄)] at ambient temperature with [Fe₂(CO)₉]. Compounds 2 – 7 have been isolated in modest yield as yellow to red crystalline solids. All the new compounds have been characterized in solution by mass spectrometry; IR spectroscopy; and ¹H, ¹¹B, and ¹³C NMR spectroscopy and the structural types were unequivocally established by crystallographic analysis of 2 – 6 .     

Bayesian uncertainty quantification of recent shock tube determinations of the rate coefficient of reaction H + O2→ OH + O

We analyze the ignition delay in hydrogen–oxygen combustion and the important chain ‐branching reaction H + O₂→ OH + O that occurs behind the shock waves in shock tube experiments. We apply a stochastic Bayesian approach to quantify uncertainties in the theoretical model and experimental data. The approach involves a statistical inverse problem, which has four “components” as input information: (a) model, (b) prior joint probability density function (PDF) of the uncertain parameters, (c) experimental data, and (d) uncertainties in the scenario parameters. The solution of this statistical inverse problem is a posterior joint PDF of the uncertain parameters from which we can easily extract statistical information. We first perform a parametric study to investigate how the level of the total uncertainty (which we define as the sum of model uncertainty and experimental uncertainty) affects the uncertainty in the rate coefficient k₁ of the reaction H + O₂→ OH + O, which is “most likely” expressed by k₁=1.73×10²³T^?2.5exp(?11550/T) cm³ mol^?1 s^?1 over the experimental temperature range 1100–1472 K. We also introduce the idea of “irreducible” uncertainty when considering other parameters in the system. After statistically calibrating the parameters modeling the rate coefficient k₁, we predict its 95% confidence interval (CI) for different temperature regimes and compare the CI against the values of k₁ obtained deterministically. Our results show that a small uncertainty in gas temperature (±5 K) introduces appreciable uncertainty in k₁. © 2012 Wiley Periodicals, Inc. Int J Chem Kinet 44: 586–597, 2012